Role of lactoferrin in neonatal care: a systematic review

References

• Patel RM. Short- and long-term outcomes for extremely preterm infants. Am J Perinatol 2016;33:318–28
   PubMed Web of Science ®Google Scholar
• Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005;115:696–703
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–65
   PubMed Web of Science ®Google Scholar
• Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255–64
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128
   PubMed Web of Science ®Google Scholar
• Rajaratnam JK, Marcus JR, Flaxman AD, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet 2010;375:1988–2008
   PubMed Web of Science ®Google Scholar
• Wang H, Liddell CA, Coates MM, et al. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:957–79
   PubMed Web of Science ®Google Scholar
• Polinski C. The value of the white blood cell count and differential in the prediction of neonatal sepsis. Neonatal Netw NN 1996;15:13–23
   PubMedGoogle Scholar
• Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am 2013;60:367–89
   PubMed Web of Science ®Google Scholar
• Borghesi A, Tzialla C, Decembrino L, et al. New possibilities of prevention of infection in the newborn. J Matern-Fetal Neonatal Med 2011;24:28–30
   PubMed Web of Science ®Google Scholar
• Borghesi A, Stronati M. Strategies for the prevention of hospital-acquired infections in the neonatal intensive care unit. J Hosp Infect 2008;68:293–300
   PubMed Web of Science ®Google Scholar
• Brady MT. Health care-associated infections in the neonatal intensive care unit. Am J Infect Control 2005;33:268–75
   PubMed Web of Science ®Google Scholar
• Manzoni P, Decembrino L, Gallo E, et al. [Recent advances in prevention of sepsis in the preterm neonate]. Recenti Prog Med 2010;101:483–9
   PubMedGoogle Scholar
• Kirpal H, Gathwala G, Chaudhary U, Sharma D. Prophylactic fluconazole in very low birth weight infants admitted to neonatal intensive care unit: randomized controlled trial. J Matern-Fetal Neonatal Med 2016;29:624–8
   PubMed Web of Science ®Google Scholar
• Cleminson J, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2015;10:CD003850
   PubMed Web of Science ®Google Scholar
• Gupta B, Vaswani ND, Sharma D, et al. Evaluation of efficacy of skin cleansing with chlorhexidine in prevention of neonatal nosocomial sepsis – a randomized controlled trial. J Matern-Fetal Neonatal Med 2014;29:242–7
   PubMed Web of Science ®Google Scholar
• Sharma D, Gathwala G. Impact of chlorhexidine cleansing of the umbilical cord on cord separation time and neonatal mortality in comparison to dry cord care – a nursery-based randomized controlled trial. J Matern-Fetal Neonatal Med 2014;27:1262–5
   PubMed Web of Science ®Google Scholar
• Gathwala G, Sharma D, Bhakhri BK. Effect of topical application of chlorhexidine for umbilical cord care in comparison with conventional dry cord care on the risk of neonatal sepsis: a randomized controlled trial. J Trop Pediatr 2013;59:209–13
   PubMed Web of Science ®Google Scholar
• Sharma DK, Gathwala G, Shastri S. Chlorhexidine – a novel intervention to decrease the nursery stay and antibiotic exposure duration – randomized trial. J Matern-Fetal Neonatal Med 2016;29:213–7
   PubMed Web of Science ®Google Scholar
• Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev 2003(4);CD003312
   PubMedGoogle Scholar
• Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 2001;285:413–20
   PubMed Web of Science ®Google Scholar
• WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet 2000;355:451–5
   PubMed Web of Science ®Google Scholar
• Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006;368:1271–83
   PubMed Web of Science ®Google Scholar
• Obladen M. Necrotizing enterocolitis – 150 years of fruitless search for the cause. Neonatology 2009;96:203–10
   PubMed Web of Science ®Google Scholar
• Miner CA, Fullmer S, Eggett DL, Christensen RD. Factors affecting the severity of necrotizing enterocolitis. J Matern-Fetal Neonatal Med 2013;26:1715–19
   PubMed Web of Science ®Google Scholar
• Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009;44:1072–5
   PubMed Web of Science ®Google Scholar
• Fanaro S. Strategies to improve feeding tolerance in preterm infants. J Matern-Fetal Neonatal Med 2012;25:54–6
   PubMed Web of Science ®Google Scholar
• Athalye-Jape G, More K, Patole S. Progress in the field of necrotizing enterocolitis – year 2012. J Matern-Fetal Neonatal Med 2013;26:625–32
   PubMed Web of Science ®Google Scholar
• Sharma R, Hudak ML. A clinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013;40:27–51
   PubMed Web of Science ®Google Scholar
• Manzoni P, Gallo E, Farina D. Probiotics for the neonate. J Matern-Fetal Neonatal Med 2009;22:27–30
   PubMed Web of Science ®Google Scholar
• Ramani M, Ambalavanan N. Feeding practices and necrotizing enterocolitis. Clin Perinatol 2013;40:1–10
   PubMed Web of Science ®Google Scholar
• Sherman MP, Miller MM, Sherman J, Niklas V. Lactoferrin and necrotizing enterocolitis. Curr Opin Pediatr 2014;26:146–50
   PubMed Web of Science ®Google Scholar
• Metz-Boutigue MH, Jollès J, Mazurier J, et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem FEBS 1984;145:659–76
   PubMedGoogle Scholar
• Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci CMLS 2005;62:2576–87
   PubMed Web of Science ®Google Scholar
• Kuwata H, Yip TT, Tomita M, Hutchens TW. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1998;1429:129–41
   PubMed Web of Science ®Google Scholar
• Yen C-C, Shen C-J, Hsu W-H, et al. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals Int J Role Met Ions Biol Biochem Med 2011;24:585–94
   Web of Science ®Google Scholar
• Bhimani RS, Vendrov Y, Furmanski P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 1999;86:135–44
   PubMed Web of Science ®Google Scholar
• Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002;417:552–5
   PubMed Web of Science ®Google Scholar
• Qiu J, Hendrixson DR, Baker EN, et al. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc Natl Acad Sci USA 1998;95:12641–6
   PubMed Web of Science ®Google Scholar
• Di Mario F, Aragona G, Dal Bó N, et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther 2006;23:1235–40
   PubMed Web of Science ®Google Scholar
• Laffan AM, McKenzie R, Forti J, et al. Lactoferrin for the prevention of post-antibiotic diarrhoea. J Health Popul Nutr 2011;29:547–51
   PubMed Web of Science ®Google Scholar
• Gomez HF, Ochoa TJ, Herrera-Insua I, et al. Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect Immun 2002;70:7050–3
   PubMed Web of Science ®Google Scholar
• Lupetti A, Brouwer CPJM, Bogaards SJP, et al. Human lactoferrin-derived peptide’s antifungal activities against disseminated Candida albicans infection. J Infect Dis 2007;196:1416–24
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ikeda M, Nozaki A, et al. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res Gann 1999;90:367–71
   PubMedGoogle Scholar
• Zuccotti GV, Salvini F, Riva E, Agostoni C. Oral lactoferrin in HIV-1 vertically infected children: an observational follow-up of plasma viral load and immune parameters. J Int Med Res 2006;34:88–94
   PubMed Web of Science ®Google Scholar
• Wolf JS, Li G, Varadhachary A, et al. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer Res off J Am Assoc Cancer Res 2007;13:1601–10
   PubMed Web of Science ®Google Scholar
• Zhang Y, Nicolau A, Lima CF, Rodrigues LR. Bovine lactoferrin induces cell cycle arrest and inhibits mtor signaling in breast cancer cells. Nutr Cancer 2014;66:1371–85
   PubMed Web of Science ®Google Scholar
• Sharma D, Pandita A, Kumar C. Lactoferrin and neonates: role in prevention of neonatal sepsis and necrotizing enterocolitis. J Neonatal Biol 2014;3:1000E–110
   Google Scholar
• Sharma D, Murki A, Murki S, Pratap OT. Use of lactoferrin in the newborn: where do we stand? J Matern-Fetal Neonatal Med 2015;28:1774–8
   PubMed Web of Science ®Google Scholar
• ELFIN Trial Investigators Group. Lactoferrin immunoprophylaxis for very preterm infants. Arch Dis Child Fetal Neonatal Ed 2013;98:F2–4
   PubMed Web of Science ®Google Scholar
• Sharma D, Shastri S. Lactoferrin and neonatology – role in neonatal sepsis and necrotizing enterocolitis: present, past and future. J Matern-Fetal Neonatal Med 2016;29:763–70
   PubMed Web of Science ®Google Scholar
• Pandita A, Sharma D, Kumar C. Lactoferrin and its role in neonatology: a review article. J Pediatr Neonatal Care 2015;2:00062
   Google Scholar
• Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421–8
   PubMed Web of Science ®Google Scholar
• Manzoni P, Stolfi I, Messner H, et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 2012;129:116–23
   PubMed Web of Science ®Google Scholar
• Stefanescu BM, Hétu C, Slaughter JC, et al. A pilot study of Biotene OralBalance® gel for oral care in mechanically ventilated preterm neonates. Contemp Clin Trials 2013;35:33–9
   PubMed Web of Science ®Google Scholar
• Sherman MP, Niklas V, Radmacher P, et al A clinical trial of talactoferrin to reduce infection in very preterm infants: safety and efficacy. Pediatr Acad Soc Ann Confer 2013;3360.7
   Google Scholar
• Akin IM, Atasay B, Dogu F, et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. Am J Perinatol 2014;31:1111–20
   PubMed Web of Science ®Google Scholar
• Manzoni P, Meyer M, Stolfi I, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 2014;90:S60–5
   PubMed Web of Science ®Google Scholar
• Ochoa TJ, Zegarra J, Cam L, et al. Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g. Pediatr Infect Dis J 2015;34:571–6
   PubMed Web of Science ®Google Scholar
• Kaur G, Gathwala G. Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: a randomized placebo-controlled clinical trial. J Trop Pediatr 2015;61:370–6
   PubMed Web of Science ®Google Scholar
• Barrington KJ, Assaad M-A, Janvier A. The Lacuna Trial: a double-blind randomized controlled pilot trial of lactoferrin supplementation in the very preterm infant. J Perinatol 2016;36:666–9
   PubMed Web of Science ®Google Scholar
• Manzoni P, Ilaria S, Messner H, et al. A multicenter, randomized trial on prophylactic bovine lactoferrin in preterm neonates for prevention of late-onset sepsis. Early Hum Dev 2008;84:S7–8
   PubMedGoogle Scholar
• Manzoni P, Rinaldi M, Meyer M, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in preterm very-low-birth-weight neonates: a randomized trial. Early Hum Dev 2011;87:S92
   Google Scholar
• Manzoni P, Stolfi I, Cattani S, et al. Bovine lactoferrin supplementation prevents invasive fungal infections in preterm VLBW neonates: data from a multicenter, randomized, double-blind, placebo-controlled study. Early Hum Dev 2012;88:S102
   Web of Science ®Google Scholar
• Alfaleh KM. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates. J Clin Neonatol 2012;1:17–18
   PubMedGoogle Scholar
• Alfaleh K. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. J Clin Neonatol 2012;1:68–9
   PubMedGoogle Scholar
• King JC, Cummings GE, Guo N, et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. J Pediatr Gastroenterol Nutr 2007;44:245–51
   PubMed Web of Science ®Google Scholar
• Ochoa TJ, Chea-Woo E, Baiocchi N, et al. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. J Pediatr 2013;162:349–56
   PubMed Web of Science ®Google Scholar
• Johnston WH, Ashley C, Yeiser M, et al. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial. BMC Pediatr 2015;15:173
   PubMed Web of Science ®Google Scholar
• Vecchiato L, Simionato A, Mostert M, et al. A51 bovine lactoferrin (BLF) supplementation for the prevention of clinical and laboratory-confirmed late-onset sepsis (LOS) in very low birth weight neonates (VLBW): a single-center study. Early Hum Dev 2013;89:S90
   Google Scholar
• ISRCTN – ISRCTN88261002: Enteral LactoFerrin In Neonates [Internet]. Available from: http://www.isrctn.com/ISRCTN88261002 [last accessed 28 Mar 2016]
   Google Scholar
• Oral lactoferrin supplementation for prevention of sepsis in preterm neonate – full text view – ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01821989 [last accessed 28 Mar 2016]
   Google Scholar
• ANZCTR – registration [Internet]. Available from: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=336631 [last accessed 28 Mar 2016]
   Google Scholar
• Study of talactoferrin oral solution for nosocomial infection in preterm infants – full text view – ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT00854633 [last accessed 28 Mar 2016]
   Google Scholar
• Supplementation with lactoferrin in preterm newborns – full text View – ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01172236 [last accessed 28 Mar 2016]
   Google Scholar
• ISRCTN – ISRCTN71737811: effect of prebiotic or lactoferrin supplementation in formula on the gut flora of preterm infants [Internet]. Available from: http://www.isrctn.com/ISRCTN71737811 [last accessed 28 Mar 2016]
   Google Scholar
• Lactoferrin for prevention of sepsis in infants – full text view – ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01525316 [last accessed 28 Mar 2016]
   Google Scholar
• Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2015;2:CD007137
   PubMed Web of Science ®Google Scholar